We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
-7.84%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.19B
AUM Growth
+$85M
(+2.7%)
Cap. Flow
-$861M
Cap. Flow
% of AUM
-27.01%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
89
New
17
Increased
26
Reduced
11
Closed
10
Top Buys
| 1 |
CG Oncology
CGON
|
+$75.5M |
| 2 |
Spyre Therapeutics
SYRE
|
+$67.4M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$62.8M |
| 4 |
Inspire Medical Systems
INSP
|
+$52.6M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$50.1M |
Top Sells
| 1 |
Transmedics
TMDX
|
+$50.9M |
| 2 |
Vaxcyte
PCVX
|
+$27.5M |
| 3 |
Cullinan Oncology
CGEM
|
+$22.7M |
| 4 |
TRML
Tourmaline Bio
TRML
|
+$20.8M |
| 5 |
argenx
ARGX
|
+$20.2M |
Sector Composition
| 1 | Healthcare | 60.98% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
51
DELISTED
Elevation Oncology
ELEV
| $6.69M | 0.21% |
2,477,614
+99,967
| +4% | +$376K |
|
52
Harrow
HROW
$1.6B
| $6.21M | 0.19% |
297,188
+171,221
| +136% | +$2.56M |
|
|
LBPH
53
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $5.57M | 0.17% |
+205,926
| New | +$4.06M |
|
54
Pulmonx
LUNG
$60.8M
| $4.77M | 0.15% |
752,541
| – | – |
|
|
55
Cullinan Oncology
CGEM
$1.1B
| $3.07M | 0.1% |
176,173
-1,064,692
| -86% | -$22.7M |
|
56
Outset Medical
OM
$84M
| $2.67M | 0.08% |
46,302
-113,726
| -71% | -$5.57M |
|
|
DBVT
57
DBV Technologies
DBVT
$930M
| $1.96M | 0.06% |
488,501
-295,828
| -38% | -$1.81M |
|
|
ETNB
58
DELISTED
89bio
ETNB
| $1.32M | 0.04% |
+164,227
| New | +$1.47M |
|
59
Adaptive Biotechnologies
ADPT
$3.67B
| – | – |
-1,357,490
| Closed | -$4.36M |
|
60
Arcutis Biotherapeutics
ARQT
$3.47B
| – | – |
-1,300,000
| Closed | -$12.9M |
|
61
BioCryst Pharmaceuticals
BCRX
$2.39B
| – | – |
-3,379,577
| Closed | -$17.2M |
|
62
BioMarin Pharmaceuticals
BMRN
$11.4B
| – | – |
-218,896
| Closed | -$19.1M |
|
63
Structure Therapeutics
GPCR
$3.53B
| – | – |
-435,823
| Closed | -$18.7M |
|
|
ITOS
64
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-1,162,374
| Closed | -$15.9M |
|
65
Mineralys Therapeutics
MLYS
$2.41B
| – | – |
-1,147,154
| Closed | -$14.8M |
|
66
Olema Pharmaceuticals
OLMA
$1.03B
| – | – |
-704,344
| Closed | -$7.97M |
|
|
TRML
67
DELISTED
Tourmaline Bio
TRML
| – | – |
-906,820
| Closed | -$20.8M |
|
|
DCPH
68
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-609,643
| Closed | -$9.59M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM